Home › Glioblastoma › Washington › Seattle
Glioblastoma clinical trials in Seattle, WA
8 studies for Glioblastoma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
RecruitingPhase 1/2
- Fred Hutchinson Cancer Research Center, Seattle
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Fred Hutch Cancer Center, Seattle
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
RecruitingPhase 1/2
- University of Washington Fred Hutchinson Cancer Center, Seattle
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Seattle Children's Hospital, Seattle
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Seattle Children's Hospital, Seattle
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Seattle Children's Hospital, Seattle
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Seattle Children's Hospital, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Seattle
Glioblastoma trials in other cities
- New York City, NY30 studies
- Houston, TX27 studies
- Boston, MA27 studies
- Los Angeles, CA23 studies
- Durham, NC19 studies
- San Francisco, CA19 studies
- Chicago, IL15 studies
- Rochester, MN14 studies
- Washington, DC14 studies
- Columbus, OH14 studies
- Miami, FL14 studies
- Jacksonville, FL13 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)48 studies
- Prostate Cancer45 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Breast Cancer37 studies
- Colorectal Cancer35 studies
- Lung Cancer34 studies
- Ovarian Cancer29 studies
- Pancreatic Cancer22 studies
- Multiple Myeloma22 studies
- Acute Lymphoblastic Leukemia22 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.